RxDoctor Payments Data

Jason Snyder, DPM

Foot & Ankle Surgery · New York, NYNPI 1003106444

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (32.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Medtronic at 49.5% of the total. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$79,217in general payments, 2019–2025

Across 272 payments — averaging $291.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$39K
  • Royal Biologics, Inc.$11K
  • Medshape, Inc.$6K
  • Novastep Inc.$4K
  • Linvatec Corporation$4K
  • Trilliant Surgical LLC.$3K
  • plus $13K from 28 others

What the payments were for

  • Consulting fees$25,92033%
  • Speaking & faculty fees$22,78229%
  • Travel & lodging$13,61617%
  • Food & beverage$16,78321%
  • Education$840%
  • Gifts$320%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$79,217 in reported general payments places this provider in the 95th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$109,038
Medicare patients
230
Services billed
2,346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluconazole29$3,995
Fluocinonide40$3,529
Ammonium Lactate127$2,729
Doxepin Hcl24$2,678
Ciclopirox143$2,639
Clotrimazole37$1,991
Ketoconazole31$982
CiclopiroxCiclopirox Olamine27$704
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip27$499
Diclofenac Sodium13$330
Mupirocin11$136
Meloxicam27$37

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →